Based on the results, the combinatorial presence of mutated Kras (codon 12) and methylated RASSF1A, FHIT and MGMT genes better characterize advanced tumor stage, metastatic disease, higher grade tumors and presence of lymphatic invasion than when considered separately. The gene discussed is KRAS; the disease is neoplasm.